Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-10-22

FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application to update the labeling for VISINE ALLERGY EYE RELIEF MULTI-ACTION, a combination eye drop containing naphazoline hydroch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VISINE ALLERGY EYE RELIEF MULTI-ACTION (Naphazoline hydrochloride and pheniramine maleate)

Snippet

SUPPL AP for VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)